These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 20306031)

  • 21. Proceedings of the ASTRO's Systemic Targeted Radionuclide Therapy Symposium. November 12-13, 2005. La Jolla, California, USA.
    Int J Radiat Oncol Biol Phys; 2006; 66(2 Suppl):S2-99. PubMed ID: 17068852
    [No Abstract]   [Full Text] [Related]  

  • 22. Evaluation of effects on the peritoneum after intraperitoneal α-radioimmunotherapy with (211)At.
    Cederkrantz E; Angenete E; Bäck T; Falk P; Haraldsson B; Ivarsson ML; Jensen H; Lindegren S; Hultborn R; Jacobsson L
    Cancer Biother Radiopharm; 2012 Aug; 27(6):353-64. PubMed ID: 22690847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody-guided radiation therapy of cancer.
    Koppe MJ; Postema EJ; Aarts F; Oyen WJ; Bleichrodt RP; Boerman OC
    Cancer Metastasis Rev; 2005 Dec; 24(4):539-67. PubMed ID: 16408161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alpha-particle-emitting radioisotopes coupled to antibody for acute myeloid leukaemia treatment.
    Featherstone C
    Mol Med Today; 1997 Jun; 3(6):232-3. PubMed ID: 9211409
    [No Abstract]   [Full Text] [Related]  

  • 25. Radioimmunotherapy of cancer with high linear energy transfer (LET) radiation delivered by radionuclides emitting α-particles or Auger electrons.
    Aghevlian S; Boyle AJ; Reilly RM
    Adv Drug Deliv Rev; 2017 Jan; 109():102-118. PubMed ID: 26705852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The promise of targeted {alpha}-particle therapy.
    Mulford DA; Scheinberg DA; Jurcic JG
    J Nucl Med; 2005 Jan; 46 Suppl 1():199S-204S. PubMed ID: 15653670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dosimetry and Radiobiology of Alpha-Particle Emitting Radionuclides.
    Sgouros G; Hobbs R; Josefsson A
    Curr Radiopharm; 2018; 11(3):209-214. PubMed ID: 29697036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer radioimmunotherapy with alpha-emitting nuclides.
    Couturier O; Supiot S; Degraef-Mougin M; Faivre-Chauvet A; Carlier T; Chatal JF; Davodeau F; Cherel M
    Eur J Nucl Med Mol Imaging; 2005 May; 32(5):601-14. PubMed ID: 15841373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Future Vistas in Alpha Therapy of Infectious Diseases.
    Dadachova E
    J Med Imaging Radiat Sci; 2019 Dec; 50(4 Suppl 1):S49-S52. PubMed ID: 31427256
    [No Abstract]   [Full Text] [Related]  

  • 30. Targeted alpha therapy: part I.
    Elgqvist J
    Curr Radiopharm; 2011 Jul; 4(3):176. PubMed ID: 22201706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pretargeted radioimmunotherapy with α-particle emitting radionuclides.
    Lindegren S; Frost SH
    Curr Radiopharm; 2011 Jul; 4(3):248-60. PubMed ID: 22201711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protein targeting constructs in alpha therapy.
    Olafsen T; Elgqvist J; Wu AM
    Curr Radiopharm; 2011 Jul; 4(3):197-213. PubMed ID: 22201709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ac-225 and her daughters: the many faces of Shiva.
    McDevitt MR; Scheinberg DA
    Cell Death Differ; 2002 Jun; 9(6):593-4. PubMed ID: 12032666
    [No Abstract]   [Full Text] [Related]  

  • 34. Alpha-emitters for immuno-therapy: a review of recent developments from chemistry to clinics.
    Huclier-Markai S; Alliot C; Varmenot N; Cutler CS; Barbet J
    Curr Top Med Chem; 2012; 12(23):2642-54. PubMed ID: 23339760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibodies in the treatment of lymphoma.
    Harvey ML; Illidge T; Johnson P
    Clin Oncol (R Coll Radiol); 2001; 13(4):251-61. PubMed ID: 11554621
    [No Abstract]   [Full Text] [Related]  

  • 36. Pretargeted alpha emitting radioimmunotherapy using (213)Bi 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid-biotin.
    Yao Z; Zhang M; Garmestani K; Axworthy DB; Mallett RW; Fritzberg AR; Theodore LJ; Plascjak PS; Eckelman WC; Waldmann TA; Pastan I; Paik CH; Brechbiel MW; Carrasquillo JA
    Clin Cancer Res; 2004 May; 10(9):3137-46. PubMed ID: 15131055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of Targeted Alpha Therapy from Bench to Bedside.
    Morgenstern A; Bruchertseifer F
    J Med Imaging Radiat Sci; 2019 Dec; 50(4S1):S18-S20. PubMed ID: 31405818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cure of Human Ovarian Carcinoma Solid Xenografts by Fractionated α-Radioimmunotherapy with
    Bäck T; Chouin N; Lindegren S; Kahu H; Jensen H; Albertsson P; Palm S
    J Nucl Med; 2017 Apr; 58(4):598-604. PubMed ID: 27688477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of different classes of radionuclides for potential use in radioimmunotherapy.
    Karagiannis TC
    Hell J Nucl Med; 2007; 10(2):82-8. PubMed ID: 17684582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validating α-particle emission from 211At-labeled antibodies in single cells for cancer radioimmunotherapy using CR-39 plastic nuclear track detectors.
    Kodaira S; Li HK; Konishi T; Kitamura H; Kurano M; Hasegawa S
    PLoS One; 2017; 12(6):e0178472. PubMed ID: 28658304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.